Text this: 114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING.